Old Drug, New Treatment?: Harvard Medical School
April 09, 2020
April 09, 2020
BOSTON, Massachusetts, April 9 -- Harvard Medical School issued the following news:
* * *
- Trial to assess anticlotting medication to treat COVID-19-related respiratory failure
* * *
While the majority of people with COVID-19 won't require hospitalization, those who do are likely to seek medical help as a result of acute respiratory distress syndrome (ARDS), a severe lung injury common in patients with critical illnesses. At present, there is . . .
* * *
- Trial to assess anticlotting medication to treat COVID-19-related respiratory failure
* * *
While the majority of people with COVID-19 won't require hospitalization, those who do are likely to seek medical help as a result of acute respiratory distress syndrome (ARDS), a severe lung injury common in patients with critical illnesses. At present, there is . . .